drugset / Trial / NCT00290173

Ritodrine in Oral Maintenance of Tocolysis After Active Preterm Labor

NCT00290173

RandomizedSingle-groupOpen-labelTreatment

Summary

This is a trial comparing the efficacy of oral ritodrine in the form of sustained release capsules for the maintenance of uterine quiescence after successfully treated episode of threatened preterm labor.

Timeline

Start
Primary completion
Completion
2005-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Ritodrine Small molecule 80 mg Oral

Indications